Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 6/2014

01-06-2014 | RHINITIS (JJ OPPENHEIMER AND J CORREN, SECTION EDITORS)

Nonallergic Rhinitis

Authors: Phil Lieberman, Debendra Pattanaik

Published in: Current Allergy and Asthma Reports | Issue 6/2014

Login to get access

Abstract

Rhinitis is normally defined by the symptoms of nasal congestion, postnasal drainage, rhinorrhea, and sneezing. It has been associated with various pathologic changes, but can occur in the absence of any inflammation. Thus, the diagnosis is based on the clinical presentation. There are no clear-cut criteria to distinguish when rhinitis becomes chronic, but in its chronic form, it can be complex. Chronic forms of rhinitis that occur in the absence of any detectable specific IgE against relevant aeroallergens in its broadest sense can be called chronic nonallergic rhinitis. This review will concentrate on chronic nonallergic rhinitis in its various forms, discussing the epidemiology, underlying mechanisms, and its therapy.
Literature
1.
Wallace DV, Dykewicz MS. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008;122:S1–S84.PubMed
2.
Blom HM, Godthelp T, Fokkens WJ, et al. Mast cells, eosinophils and IgE-positive cells in nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngol. 1995;252 Suppl 1:S33–9.PubMed
3.
Powe DG, Huskisson RS, Carney AS, et al. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31:864–72.PubMed
4.
Middleton Jr E. Chronic rhinitis in adults. J Allergy Clin Immunol. 1988;81:971.PubMed
5.
Mullarkey MF, Hill JS, Webb DR. Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol. 1980;65:122.PubMed
6.
Enberg RN. Perennial nonallergic rhinitis: a retrospective review. Ann Allergy. 1989;63:513.PubMed
7.
Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999;104:301.PubMed
8.
Togias A. Age relationships and clinical features of nonallergic rhinitis. J Allergy Clin Immunol. 1990;85:182.
9.
Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;86:494.PubMed
10.
Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006;61:693.PubMed
11.
Mølgaard E, Thomsen SF, Lund T, et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy. 2007;62:1033.PubMed
12.
Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122:S1.PubMed
13.
Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998;81:478.PubMed
14.
Togias AK. Nonallergic rhinitis. In: Allergic and nonallergic rhinitis: clinical aspects, Mygine N, Naclerio RM (Eds), Munksgaard, Copenhagen 1993; p.159.
15.
Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19(23):58.
16.
Berger WE, Schonfeld JE. Nonallergic rhinitis in children. Curr Allergy Asthma Rep. 2007;7:112.PubMed
17.
Chawes BL, Kreiner-Møller E, Bisgaard H. Objective assessments of allergic and nonallergic rhinitis in young children. Allergy. 2009;64:1547.PubMed
18.
Erwin EA, Faust RA, Platts-Mills TA, Borish L. Epidemiological analysis of chronic rhinitis in pediatric patients. Am J Rhinol Allergy. 2011;25:327.PubMed
19.
Westman M, Stjärne P, Asarnoj A, et al. Natural course and comorbidities of allergic and nonallergic rhinitis in children. J Allergy Clin Immunol. 2012;129:403. Chronic non-allergic rhinitis has been a well-recognized entity in adults, but until recently it was thought to be rare in children. This reference dispels that opinion and discusses the importance of non-allergic rhinitis in children.PubMed
20.
Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc. 2003;24:147.PubMed
21.
Settipane GA, Klein DE. Non allergic rhinitis: demography of eosinophils in nasal smear, blood total eosinophil counts and IgE levels. N Engl Reg Allergy Proc. 1985;6:363.PubMed
22.
Powe DG, Huskisson RS, Carney AS, et al. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31:864.PubMed
23.
Berger G, Goldberg A, Ophir D. The inferior turbinate mast cell population of patients with perennial allergic and nonallergic rhinitis. Am J Rhinol. 1997;11:63.PubMed
24.
Canakcioglu S, Tahamiler R, Saritzali G, et al. Evaluation of nasal cytology in subjects with chronic rhinitis: a 7-year study. Am J Otolaryngol. 2009;30(5):312–7.PubMed
25.
Schiavino D, Nucera E, Milani A, Della Corte AM, D'Ambrosio C, Pagliari G, et al. Nasal lavage cytometry in the diagnosis of nonallergic rhinitis with eosinophilia syndrome (NARES). Allergy Asthma Proc. 1997;18(6):363–6.PubMed
26.
Maselli Del Giudice A, Barbara M, Russo GM, et al. Cell-mediated non-allergic rhinitis in children. Int J Pediatr Otorhinolaryngol. 2012;76:1741.PubMed
27.
Matteo G, Luigi MG, Amelia L, et al. Nasal cytology in children: recent advances. Ital J Pediatr. 2012;38:51. Nasal cytology has become a lost art in the assessment of rhinitis, and yet it can give important insights into the pathogenesis underlying this disorder in any given patient and therefore assist in therapy. The importance of nasal cytology is demonstrated in children with rhinitis.PubMedCentral
28.
Mullarkey MF. Eosinophilic nonallergic rhinitis. J Allergy Clin Immunol. 1998;82(5):941–9.
29.
Rinne J, Simola M, Malmberg H, Haahtela T. Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long term outcome. J Allergy Clin Immunol. 2002;109:426–32.PubMed
30.
Brooms P, Malm L. Oral vasoconstrictors in perennial non-allergic rhinitis. Allergy. 1982;37:67–74.
31.
Lieberman P. The role of antihistamines in the treatment of vasomotor rhinitis. WAO J. 2009;2:156–61.
32.
Purello-D’ Ambrosio F, Isola S, Ricciardi L, Gangemi S, Barresi L, Bagnato GF. A controlled study on the effectiveness of loratidine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES). Clin Exp Allergy. 1999;29:1143–7.
33.
Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the treatment of allergic and non-allergic rhinitis. Clin Exp Allergy. 2008;38(1):19–42.PubMed
34.
Powe DG, Jagger C, Kleinjan A, Carney AS, Jenkins D, Jones NS. “Entopy”: localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy. 2003;33:1374–9.PubMed
35.
KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J. 2000;15:491.PubMed
36.
Rondón C, Romero JJ, López S, et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol. 2007;119:899.PubMed
37.
Rondón C, Fernández J, López S, et al. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. J Allergy Clin Immunol. 2009;124:1005.PubMed
38.
Rondón C, Campo P, Togias A, et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129:1460.PubMed
39.
Smurthwaite L, Walker SN, Wilson DR, et al. Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol. 2001;31:3422.PubMed
40.
Smurthwaite L, Durham SR. Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep. 2002;2:231.PubMed
41.
Rondón C, Campo P, Herrera R, et al. Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis. J Allergy Clin Immunol. 2011;128:1192. The local synthesis of specific IgE to aeroallergens (without the detection of systemic specific IgE) has been demonstrated to account for rhinitis symptoms in patients previously diagnosed as having nonallergic rhinitis. In this article, it is shown that nasal allergen provocation with multiple aeroallergens can be an effective means of detecting the production of local IgE in such patients.PubMed
42.
Rondón C, Campo P, Galindo L, et al. Prevalence and clinical relevance of local allergic rhinitis. Allergy. 2012;67:1282.PubMed
43.
Wierzbicki DA, Majmundar AR, Schull DE, Khan DA. Multiallergen nasal challenges in nonallergic rhinitis. Ann Allergy Asthma Immunol. 2008;100:533.PubMed
44.
Hamilos DL. Chronic sinusitis. J Allergy Clin Immunol. 2000;106:213–27.PubMed
45.
Yoon BN, Choi NG, Lee HS, Cho KS, Roh HJ. Induction of interleukin-8 from nasal epithelial cells during bacterial infection: the role of IL-8 for neutrophil recruitment in chronic rhinosinusitis. Mediators Inflamm 2010; 8136.
46.
Calderón-Garcidueñas L, Valencia-Salazar G, Rodríguez-Alcaraz A, et al. Ultrastructural nasal pathology in children chronically and sequentially exposed to air pollutants. Am J Respir Cell Mol Biol. 2001;24(2):132–8.PubMed
47.
Einarsson O, Geba GP, Zhou Z, et al. Interleukin-11 in respiratory inflammation. Ann N Y Acad Sci. 1995;762:31–40.
48.
Baraniuk JN. Pathogenic mechanisms of idiopathic non allergic rhinitis. WAO J. 2009;2:106–14.
49.
Bernstein JA, Hastings L, Boespflug EL, et al. Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastine. Ann Allergy Asthma Immunol. 2011;106(527). This article gives an excellent insight into the neural mechanisms underlying symptoms in patients with chronic non-allergic rhinitis upon exposure to respiratory irritants. It also elucidates in part the mechanisms of action of azelastine in this condition.
50.
van Rijswijk J, Blom H, KleinJan A, Mulder P, Rijntjes E, Fokkens W. Inflammatory cells seem not to be involved in idiopathic rhinitis. Rhinology. 2002;40:1–6.
51.
Braat J, Mulder P, Fokkens W, van Wijk R, Rijntjes E. Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectiousperennial rhinitis. Am J Respir Crit Care Med. 1998;157:1748–55.PubMed
52.
Garay R. Mechanisms of Vasomotor Rhinitis. Allergy. 2004;59 Suppl 76:4–10.PubMed
53.
Lundblad L. Protective reflexes and vascular effects in the nasal mucosa elicited by activation of capsaicin sensitive substance P-immunoreactive neurons. Acta Physiol Scand. 1984;529:1–42.
54.
van Rijswijk J, Boeke E, Keizer J, Mulder P, Blom H, Fokkens W. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis:a double-blind randomized application regimen study. Allergy. 2003;58:754–61.PubMed
55.
Lacroix J, Buvelot J, Polla B, Lundberg J. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy. 1991;21:595–600.PubMed
56.
Blom H, Van Rijswijk J, Garrelds I, Mulder P, Timmermans T, Van Wijk R. Intranasal capsaicin is efficacious in non-allergic, noninfectious perennial rhinitis: a placebo-controlled study. Clin Exp Allergy. 1997;27:796–801.PubMed
57.
Sanico AM, Philip G, Lai G, Togias A. Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis. J Appl Physiol. 1999;86:1202–10.PubMed
58.
Baraniuk JN, Petrie KN, Le U, Tai CF, Park YJ, et al. Neuropathology in rhinosinusitis. Am J Respir Crit Care Med. 2005;171:5–11.PubMed
59.
Naranch K, Park YJ, Repka-Ramirez MS, et al. A tender sinus does not always mean sinusitis. Otolaryngol Head Neck Surg. 2002;127:387–97.PubMed
60.
Wilkins BW, Chung LH, Tublitz NJ, Wong BJ, Minson CT. Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin. J Appl Physiol. 2004;97:1291–8.PubMed
61.
Fokkens WJ. Thoughts on the pathophysiology of nonallergic rhinitis. Curr Allergy Asthma Rep. 2002;2:203–9.PubMed
62.
Silvers WS. The skier's nose: a model of cold induced rhinorrhea. Ann Allergy. 1991;67:32–6.PubMed
63.
Waibel KH, Chang C. Prevalence and food avoidance behaviors for gustatory rhinitis. Ann Allergy Asthma Immunol. 2008;100:200–5.PubMed
64.
Vayisoglu Y, Ozcan C, Pekdemir H, Gorur K, Pata YS, Camsari A. Autonomic nervous system evaluation using heart rate variability parameters in vasomotor rhinitis patients. J Otolaryngol. 2006;35:338–42.PubMed
65.
Wilde D, Cook JA, Jones AS. The nasal response to axillary pressure in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol Allied Sci. 1997;22:219–21.PubMed
66.
Jaradeh S, Smith T, Torrico L, Prieto T, Loehrl T, Darling R, et al. Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope. 2000;110:1828–31.PubMed
67.
Elsheikh MN, Badran HM. Dysautonomia rhinitis: associated otolaryngological manifestations and characterization based on autonomic function tests. Acta Otolaryngol. 2006;126:1206–12.PubMed
68.
Molgaard E, Thomsen SF, Lund T, Pedersen L, Nolte H, Backer V. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy. 2007;62(9):1033–7.PubMed
69.
Wedback A, Enbom H, Eriksson NE, Moverare R, Malcus I. Seasonal nonallergic rhinitis (SNAR): a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent nonallergic rhinitis. Rhinology. 2005;43:86–92.PubMed
70.
Lindberg S, Malm L. Comparison of allergic rhinitis and vasomotor rhinitis patients on the basis of a computer questionnaire. Allergy. 1993;48:602–7.PubMed
71.
Di Lorenzo G, Pacor ML, Amodio E, et al. Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms. Int Arch Allergy Immunol. 2011;155(3):263–70.PubMed
72.
Stjarne P, Lundblad L, Lundberg JM, Anggard A. Capsaicin and nicotine sensitive afferent neurons and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol. 1989;96:693–701.PubMedCentralPubMed
73.
Scarupa MD, Kaliner MA. Non-allergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations. WAO J. 2009;2(3):20–5.
74.
Chawes BL, Kreiner-Møller E, Bisgaard H. Objective assessments of allergic and nonallergic rhinitis in young children. Allergy. 2009;64(10):1547–53.PubMed
75.
Erwin EA, Faust RA, Platts-Mills TA, Borish L. Epidemiological analysis of chronic rhinitis in pediatric patients. Am J Rhinol Allergy. 2011;25(5):327–32.PubMed
76.
Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol. 2006;96(4):526–32.PubMed
77.
Bernstein JA. Characteristics of nonallergic vasomotor rhinitis. WAO J. 2009;2:102–5.
78.
Bernstein JA, Levin LS, Al-Shuik E, Martin VT. Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens. Ann Allergy Asthma Immunol. 2012;109:173–8.PubMed
79.
Segboer CL, Holland CT, Reinartz SM, Terreehorst I, Gevorgyan A, Hellings PW, et al. Nasal hyper-reactivity is a common feature in both allergic and nonallergic rhinitis. Allergy. 2013;68:1427–34. Hyperirritability of the upper airways is an important factor in patients who have abnormal responses to respiratory irritants and perhaps weather changes. It has been known that patients with non-allergic rhinitis exhibit such hyperactivity. This article demonstrates that such hyperactivity also occurs in patients with allergic rhinitis.PubMed
80.
Kaliner MA. Classification of nonallergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy. WAO J. 2009;2:98–101.
81.
Settipane GA, Klein DE. Non allergic rhinitis: demography of eosinophils in nasal smear, blood total eosinophil counts and IgE levels. N Engl Reg Allergy Proc. 1985;6(4):363–6.PubMed
82.
Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF. Non-allergic, mastocytosis-associated rhinitis. Clin Exp Allergy. 2013;43:406–12.PubMed
83.
Dzieciolowska-Baran E, Teul-Swiniarska I, Gawlikowska-Sroka A, Poziomkowska-Gesicka I, Zietek Z. Rhinitis as a cause of respiratory disorders during pregnancy. Adv Exp Med Biol. 2013;755:213–20.PubMed
84.
Reisacher WR. Prevalence of autoimmune thyroid disease in chronic rhinitis. Ear Nose Throat J. 2008;87(9):524–7.PubMed
85.
Varghese M, Glaum MC, Lockey RF. Drug-induced rhinitis. Clin Exp Allergy. 2010;40(3):381–4.PubMed
86.
Graf P, Hallén H, Juto JE. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy. 1995;25(5):395–400.PubMed
87.
Baroody FM, Brown D, Gavanescu L, DeTineo M, Naclerio RM. Oxymetazoline adds ttheeffectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011;127(4):927–34.PubMed
88.
Rael EL, Ramey J, Lockey RF. Oxymetazoline hydrochloride combined with mometasone nasal spray for persistent nasal congestion (pilot study). WAO J. 2011;4(3):65–7. Rebound rhinitis due to the administration of topical nasal decongestants has been, for many years, a well-recognized side effect of the administration of these agents. This article demonstrates that short-term use of oxymetazoline does not produce this "rebound phenomenon" when the agent is administered in conjunction with mometasone, a topical nasal steroid.
89.
Meltzer EO, Nathan RA, Derebery J, et al. Physician perceptions of the treatment and management of allergic and nonallergic rhinitis. Allergy Asthma Proc. 2009;30(1):75–83.PubMed
90.
Blom HM, Godthelp T, Fokkens WJ, et al. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol. 1997;100:739.PubMed
91.
Philip G, Togias AG. Nonallergic rhinitis. Pathophysiology and models for study. Eur Arch Otorhinolaryngol. 1995;252 Suppl 1:S27.PubMed
92.
Mullarkey MF. Eosinophilic nonallergic rhinitis. J Allergy Clin Immunol. 1988;82:941.PubMed
93.
Rinne J, Simola M, Malmberg H, Haahtela T. Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome. J Allergy Clin Immunol. 2002;109:426.PubMed
94.
Kondo H, Nachtigal D, Frenkiel S, et al. Effect of steroids on nasal inflammatory cells and cytokine profile. Laryngoscope. 1999;109:91.PubMed
95.
Malm L, Wihl JA. Intra-nasal beclomethasone dipropionate in vasomotor rhinitis. Acta Allergol. 1976;31:245.PubMed
96.
Wight RG, Jones AS, Beckingham E, et al. A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis. Clin Otolaryngol Allied Sci. 1992;17:354.PubMed
97.
Small P, Black M, Frenkiel S. Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol. 1982;70:178.PubMed
98.
Banov CH, Lieberman P. Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001;86:28.PubMed
99.
Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy. 1995;25:737.PubMed
100.
Pipkorn U, Berge T. Long-term treatment with budesonide in vasomotor rhinitis. Acta Otolaryngol. 1983;95:167.PubMed
101.
Takao A, Shimoda T, Matsuse H, et al. Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma. Ann Allergy Asthma Immunol. 1999;82:390.PubMed
102.
Ciprandi G, Pronzato C, Passalacqua G, et al. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol. 1996;98:1088.PubMed
103.
Yoneda K, Yamamoto T, Ueta E, Osaki T. Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxide. Jpn J Pharmacol. 1997;73:145.PubMed
104.
Tamaoki J, Yamawaki I, Tagaya E, et al. Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. Am J Physiol. 1999;276:L351.PubMed
105.
Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol. 1995;95:1117.PubMed
106.
Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and flutica sone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105:168.PubMed
107.
Blom HM, Godthelp T, Fokkens WJ, KleinJan A, Mulder PG, Rijntjes E. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol. 1997;100:739–47.PubMed
108.
Small P, Black M, Frenkiel S. Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol. 1982;70:178–82.PubMed
109.
Lundblad L, Sipila P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a Nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2001;121:505–9.PubMed
110.
Webb DR, Meltzer EO, Finn Jr AF, et al. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia. Ann Allergy Asthma Immunol. 2002;88:385.PubMed
111.
Jacobs R, Lieberman P, Kent E, et al. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy Asthma Proc. 2009;30:120.PubMed
112.
Pattanaik D, Lieberman P. Vasomotor rhinitis. Curr Allergy Asthma Rep. 2010;10(2):84–91.PubMed
113.
Smith PK, Collins J. Olopatadine 0.6 % nasal spray protects from vasomotor challenge in patients with severe vasomotor rhinitis. Am J Rhinol Allergy. 2011;25:e149.PubMed
114.
Lieberman P, Meltzer EO, LaForce CF, et al. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6 % versus azelastine hydrochloride nasal spray 0.1 % in patients with vasomotor rhinitis. Allergy Asthma Proc. 2011;32:151.PubMed
115.
Lieberman P. Intranasal antihistamines for allergic rhinitis: mechanism of action. Allergy Asthma Proc. 2009;30:345.PubMed
116.
Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol. 2012;129:1282.PubMed
117.
Raphael G, Raphael MH, Kaliner M. Gustatory rhinitis: a syndrome of food-induced rhinorrhea. J Allergy Clin Immunol. 1989;83:110.PubMed
118.
Georgalas C, Jovancevic L. Gustatory rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2012;20:9.PubMed
119.
Hatton RC, Winterstein AG, McKelvey RP, et al. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother. 2007;41:381.PubMed
120.
Horak F, Zieglmayer P, Zieglmayer R, et al. A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber. Ann Allergy Asthma Immunol. 2009;102:116.PubMed
121.
Lanier BQ, Meltzer EO, Gates D, Shekar T, Teper A. Onset and duration of action of concomitant administration of mometasone furoate nasal spray with oxymetazoline nasal spray versus either drug alone and placebo in subjects with seasonal allergic rhinitis. J Allergy Clin Immunol. 2010;4(2):AB173.
122.
Gross G, Meltzer EO, Gates D, Shekar T, Teper A. Impact of concomitant administration of mometasone furoate and oxymetazoline nasal sprays vs either drug alone or placebo on quality of life in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2010;4(2):AB174.
123.
Nayak AS, Prenner B, Gates D, Shekar T, Teper A. Tolerability of concomitant administration of mometasone furoate and oxymetazoline nasal sprays administered once daily vs oxymetazoline twice daily, mometasone furoate once daily, and placebo in the treatment of subjects with seasonal allergic rhinitis. J Allergy Clin Immunol. 2010;4(2):AB175.
124.
Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;137(4):532–4. CD006394.
125.
Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000;110:1189.PubMed
126.
Spector SL. The placebo effect is nothing to sneeze at. J Allergy Clin Immunol. 1992;90:1042.PubMed
127.
Pynnonen MA, Mukerji SS, Kim HM, et al. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg. 2007;133:1115.PubMed
128.
Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Van Gerth WR. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis: a placebo-controlled study. Clin Exp Allergy. 1997;27(7):796–801.PubMed
129.
Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PG, Blom HM, Fokkens WJ. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy. 2003;58(8):754–61.PubMed
130.
Marabini S, Ciabatti PG, Polli G, et al. Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis. Eur Arch Otorhinolaryngol. 1991;248:191.PubMed
131.
Bernstein JA, Davis BP, Picard JK, Cooper JP, Zheng S, Levin LS. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol. 2011;107(2):171–8.PubMed
132.
Erhan E, Külahli I, Kandemir O, Cemiloglu R, Yigitbasi OG, Cüreoglu S. Comparison of topical silver nitrate and flunisolide treatment in patients with idiopathic non-allergic rhinitis. Tokai J Exp Clin Med. 1996;21:103–11.PubMed
133.
Samarrae SM. Treatment of 'vasomotor rhinitis' by the local application of silver nitrate. J Laryngol Otol. 1991;105:285–7.
134.
Bhargava KB, Shirali GN, Abhyankar US, Gadre KC. Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate. J Laryngol Otol. 1992;106:699–701.PubMed
135.
Davies A, Lewith G, Goddard J, Howarth P. The effect of acupuncture on nonallergic rhinitis: a controlled pilot study. Altern Ther Health Med. 1998;4(1):70–4.PubMed
136.
Fleckenstein J, Raab C, Gleditsch J, Ostertag P, Rasp G, Stör W, et al. Impact of acupuncture on vasomotor rhinitis: a randomized placebo-controlled pilot study. J Altern Complement Med. 2009;15:391–8.PubMed
137.
Mladina R, Risavi R, Subaric M. CO2 laser anterior turbinectomy in the treatment of non-allergic vasomotor rhinopathia. A prospective study upon 78 patients. Rhinology. 1991;29:267.PubMed
138.
Fernandes CM. Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. J Laryngol Otol. 1994;108:569.PubMed
139.
Prasanna A, Murthy PS. Vasomotor rhinitis and sphenopalatine ganglion block. J Pain Symptom Manag. 1997;13:332.
Metadata
Title
Nonallergic Rhinitis
Authors
Phil Lieberman
Debendra Pattanaik
Publication date
01-06-2014
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 6/2014
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-014-0439-3

Other articles of this Issue 6/2014

Current Allergy and Asthma Reports 6/2014 Go to the issue

ANAPHYLAXIS AND DRUG ALLERGY (DA KHAN AND M CASTELLS, SECTION EDITORS)

Skin Testing and Patch Testing in Non-IgE-Mediated Drug Allergy

BASIC AND APPLIED SCIENCE (M FRIERI AND PJ BRYCE, SECTION EDITORS)

Good’s Syndrome, CVID, and Selective Antibody Deficiency in Patients with Chronic Rhinosinusitis

RHINOSINUSITIS (J MULLOL, SECTION EDITOR)

Management of Chronic Rhinosinusitis in Asthma Patients: Is There Still a Debate?

IMMUNOLOGIC/DIAGNOSTIC TESTS IN ALLERGY (JL SCHMITZ, SECTION EDITOR)

Metabolomics Approach in Allergic and Rheumatic Diseases

Invited Commentary

Invited Commentary: Recommendation for a North American Pediatric Patch Test Series

RHINOSINUSITIS (J MULLOL, SECTION EDITOR)

Aspirin Desensitization: Useful Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Aspirin-Exacerbated Respiratory Disease (AERD)?